Theravance Biopharma Inc (TBPH) Net Margin

Official company branding of Theravance Biopharma, Inc. (TBPH)

Sales margin dynamics confirm that Theravance Biopharma (TBPH) is transitioning toward extracting profit from approved drugs and restructuring its obligations. The stability of these metrics is based on inelastic demand and the organ-selectivity of the medications, as well as strategic alliances with industry behemoths for distribution. The current level of this indicator is 51.60, illustrating the efficiency of converting revenue into net income.

theravance.com (TBPH) - Net Sales Margin from 07/04/2022 to 10/10/2026

TBPH (Theravance Corp): analytical breakdowns and indicator data

- share price and expert price forecast:
Summary company analysis:Theravance Biopharma Inc - TBPH
Flagship merchandise of Theravance

For Theravance Biopharma (TBPH), which develops selective drugs for the treatment of respiratory pathologies, the net operating margin serves as an indicator of the efficiency of innovation monetization. This metric is calculated as the ratio of net income to total revenue, allowing investors to filter out speculative noise and assess the actual profit share that confirms long-term capital sustainability and the business's operational return.

Main competitors

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|AQST (Aquestive Therapeutics) - Net Profit Rate|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma